NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹39 Cr | ₹34 Cr | ₹-25 Cr | ₹-0.81 Cr | - |
What is the latest Net Cash Inflow / Outflow ratio of NATH BIOGENES (INDIA) ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹39 Cr |
Mar2023 | ₹34 Cr |
Mar2022 | ₹-25 Cr |
Mar2013 | ₹-0.81 Cr |
Mar2012 | - |
How is Net Cash Inflow / Outflow of NATH BIOGENES (INDIA) Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹39 Cr | 16.56 | |
Mar2023 | ₹34 Cr | Positive | |
Mar2022 | ₹-25 Cr | Negative | |
Mar2013 | ₹-0.81 Cr | 0 | |
Mar2012 | - | - |
Compare Net Cash Inflow / Outflow of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹286.3 Cr | -6.4% | -10.1% | -25% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹11,592.2 Cr | -9.5% | -21.2% | -0.4% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,148.0 Cr | 2.1% | 11% | 55.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,301.8 Cr | -1.3% | -9.9% | -9.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,405.4 Cr | -7% | -12.6% | -38.5% | Stock Analytics | |
INDO US BIOTECH | ₹394.8 Cr | -9.8% | -10.3% | -14.4% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -6.4% |
-10.1% |
-25% |
SENSEX | -3.4% |
-4.4% |
0.6% |
You may also like the below Video Courses